ModelEdge

Jasper Therapeutics Inc.

Filing Type	8-K
Filing Date	7/16/2026
Updated	7/16/26, 7:50 PM

Filing

Earnings Release

Exhibits

8-KMaterial Contracts, Completing Asset Acquisition or Sale, Unregistered Sales of Equity Securities, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Reg. FD

EX-2.1AGREEMENT AND PLAN OF MERGER, DATED JULY 16, 2026, BY AND AMONG JASPER THERAPEUTICS, INC., KIRA HOLDCO INC. AND KIRA PHARMACEUTICALS

EX-3.1JASPER THERAPEUTICS, INC. CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF NON-VOTING CONVERTIBLE PREFERRED STOCK

EX-10.1FORM OF SECURITIES PURCHASE AGREEMENT, DATED AS OF JULY 16, 2026, BY AND AMONG JASPER THERAPEUTICS, INC. AND EACH INVESTOR LISTED ON EXHIBIT A THERETO

EX-10.2FORM OF REGISTRATION RIGHTS AGREEMENT, BY AND AMONG JASPER THERAPEUTICS, INC. AND THE INVESTORS SIGNATORY THERETO

EX-99.1Material Contracts, Completing Asset Acquisition or Sale, Unregistered Sales of Equity Securities, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Reg. FD